Table 1 | Demographic and clinical..

	Standard therapy (metformin+diet+exercise) n=20	Silphos-selenium-methionine –alphalipoic acid-standard therapy n=20	Statistical significance P <0.05*
Age(years)	49.5(41.25-53.75)	44(36.7-54)	0.50
Gender (Female)	14(70%)	12(60%)	0.32
Metabolic syndrome
Pre-Diabetes	20(100%)	20(100%)	0.59
Dyslipdemia	5 (25%)	3(15%)	0.69
Hypertension	6 (30%)	6 (30%)	0.23
Baseline steatosis Degree (Echsongraphy)
Mild	0	2(10%)
Moderate	11(55%)	7(35%)	0.14
serious	9(45%)	11 (55%)	0.11
NAFLD Hepatic Biopsy
Steatosis	10 (50%)	10(50%)

Data expressed as medians (MD) and percentiles (P25-75) or rates and Percentage %

Table 1: Demographic and clinical characteristics

Goto home»